Sun Y - Search Results

1

Expression of the proteasome activator PA28 rescues the presentation of a cytotoxic T lymphocyte epitope on melanoma cells.

Sun Y, Sijts AJ, Song M, Janek K, Nussbaum AK, Kral S, Schirle M, Stevanovic S, Paschen A, Schild H, Kloetzel PM, Schadendorf D. Sun Y, et al. Cancer Res. 2002 May 15;62(10):2875-82. Cancer Res. 2002. PMID: 12019167

2

Identification of a new HLA-A(*)0201-restricted T-cell epitope from the tyrosinase-related protein 2 (TRP2) melanoma antigen.

Sun Y, Song M, Stevanović S, Jankowiak C, Paschen A, Rammensee HG, Schadendorf D. Sun Y, et al. Int J Cancer. 2000 Aug 1;87(3):399-404. doi: 10.1002/1097-0215(20000801)87:3<399::aid-ijc14>3.0.co;2-9. Int J Cancer. 2000. PMID: 10897046

3

Identification of known and novel immunogenic T-cell epitopes from tumor antigens recognized by peripheral blood T cells from patients responding to IL-2-based treatment.

Scheibenbogen C, Sun Y, Keilholz U, Song M, Stevanovic S, Asemissen AM, Nagorsen D, Thiel E, Rammensee HG, Schadendorf D. Scheibenbogen C, et al. Among authors: sun y. Int J Cancer. 2002 Mar 20;98(3):409-14. doi: 10.1002/ijc.10205. Int J Cancer. 2002. PMID: 11920592

4

Gene-based immunotherapy of skin cancers.

Sun Y, Schadendorf D. Sun Y, et al. Recent Results Cancer Res. 2002;160:170-84. doi: 10.1007/978-3-642-59410-6_21. Recent Results Cancer Res. 2002. PMID: 12079212 Review.

5

Human CD4+ T lymphocytes recognize a vascular endothelial growth factor receptor-2-derived epitope in association with HLA-DR.

Sun Y, Song M, Jäger E, Schwer C, Stevanovic S, Flindt S, Karbach J, Nguyen XD, Schadendorf D, Cichutek K. Sun Y, et al. Clin Cancer Res. 2008 Jul 1;14(13):4306-15. doi: 10.1158/1078-0432.CCR-07-4849. Clin Cancer Res. 2008. PMID: 18594014

6

Cell-based vaccination against melanoma--background, preliminary results, and perspective.

Sun Y, Paschen A, Schadendorf D. Sun Y, et al. J Mol Med (Berl). 1999 Aug;77(8):593-608. doi: 10.1007/s001099900039. J Mol Med (Berl). 1999. PMID: 10543391 Review.

7

Autologous, allogeneic tumor cells or genetically engineered cells as cancer vaccine against melanoma.

Schadendorf D, Paschen A, Sun Y. Schadendorf D, et al. Among authors: sun y. Immunol Lett. 2000 Sep 15;74(1):67-74. doi: 10.1016/s0165-2478(00)00251-0. Immunol Lett. 2000. PMID: 10996630 Review.

8

Segregation of effector mechanisms in a tumour-specific CD8+ T-cell clone correlates with CD30 expression.

Sun Y, Song M, Maeurer MJ, Schadendorf D. Sun Y, et al. Scand J Immunol. 2001 Sep;54(3):314-20. doi: 10.1046/j.1365-3083.2001.00971.x. Scand J Immunol. 2001. PMID: 11555396 Free article.

9

The kinase insert domain-containing receptor is an angiogenesis-associated antigen recognized by human cytotoxic T lymphocytes.

Sun Y, Stevanovic S, Song M, Schwantes A, Kirkpatrick CJ, Schadendorf D, Cichutek K. Sun Y, et al. Blood. 2006 Feb 15;107(4):1476-83. doi: 10.1182/blood-2005-05-1912. Epub 2005 Oct 18. Blood. 2006. PMID: 16234362 Free article.

10

In vivo selective expansion of a tumour-specific cytotoxic T-cell clone derived from peripheral blood of a melanoma patient after vaccination with gene-modified autologous tumour cells.

Sun Y, Möller P, Berking C, Schlüpen EM, Volkenandt M, Schadendorf D. Sun Y, et al. Immunology. 1999 Dec;98(4):535-40. doi: 10.1046/j.1365-2567.1999.00902.x. Immunology. 1999. PMID: 10594685 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

65,078 results

Search Page

Filters